2008
DOI: 10.1016/j.jchromb.2008.07.041
|View full text |Cite
|
Sign up to set email alerts
|

Determination of rimonabant in human plasma and hair by liquid chromatography–mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Europe for the treatment of obesity (now withdrawn from the market), an LC-MS/MS protocol for its detection in human plasma and hair was published, allowing to ascertain daily and long-term compliance/intake [80]. Similar strategies were followed for (i) clozapine, to elucidate a unauthorized long-term administration on psychiatric patients [81]; (ii) risperidone an antipsychotic drug of second generation [82]; and (iii) atomoxetine, a non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric and non-pediatric patients as an alternative to methylphenidate (MPH) [83].…”
Section: Shortly After the Introduction Of Rimonabant As The First Ca...mentioning
confidence: 99%
“…Europe for the treatment of obesity (now withdrawn from the market), an LC-MS/MS protocol for its detection in human plasma and hair was published, allowing to ascertain daily and long-term compliance/intake [80]. Similar strategies were followed for (i) clozapine, to elucidate a unauthorized long-term administration on psychiatric patients [81]; (ii) risperidone an antipsychotic drug of second generation [82]; and (iii) atomoxetine, a non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric and non-pediatric patients as an alternative to methylphenidate (MPH) [83].…”
Section: Shortly After the Introduction Of Rimonabant As The First Ca...mentioning
confidence: 99%